Duloxetine Capsule, Delayed Release
Product Images NDC 68071-3519

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 68071-3519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3519 3)

FDA Label Image

Figure1 (Duloxetine Fig1)

FDA Label Image

Figure10 (Duloxetine Fig10)

FDA Label Image

Figure2 (Duloxetine Fig2)

This text appears to be a graph showing the proportion of patients with relapse over time. The x-axis represents the time from randomization to relapse in days, while the y-axis represents the proportion of patients with relapse. The graph compares the treatment outcomes of a placebo group and a group treated with duloxetine.*

FDA Label Image

Figure3 (Duloxetine Fig3)

FDA Label Image

Figure4 (Duloxetine Fig4)

FDA Label Image

Figure5 (Duloxetine Fig5)

FDA Label Image

Figure6 (Duloxetine Fig6)

FDA Label Image

Figure7 (Duloxetine Fig7)

This text provides information about the percentage of patients improved, along with a graph showing the improvement in pain from baseline. The graph includes data points for duloxetine 60 mg once daily and placebo. However, without further context or additional readable text, it is not possible to provide a more specific description.*

FDA Label Image

Figure8 (Duloxetine Fig8)

FDA Label Image

Figure9 (Duloxetine Fig9)

FDA Label Image

Structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.